Trial Profile
A randomized phase II study of Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2009
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms OESOTUX
- 01 Oct 2009 Results published in Allergy and Asthma Proceedings.